Wilmer Cutler Pickering Hale and Dorr has advised Enavate Sciences. Goodwin Procter has advised Braveheart Bio. Enavate Sciences, a platform of Patient Square Capital, has made...
Enavate Sciences Invests in Braveheart Bio’s $185 Million Series A Financing
Zenas BioPharma’s $118 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised lead investor Enavate Sciences and new investor Longitude Capital in the financing. Global pharmaceutical company Zenas BioPharma announced a $118...


























